President Donald Trump continued to promote unproven links between Tylenol and autism, stating "Taking Tylenol is, uh, not good. I'll say it. It's not good," during an unspecified event. The Associated Press reported that Trump used the platform of the presidency to promote these ties without new evidence. Simultaneously, the NIH announced the launch of its Autism Data Science Initiative, dedicating an additional $50 million to autism research, as stated by NIH Director Jay. These statements and developments occurred within a 30-minute window on September 22nd, 2025. The timing of Trump's remarks is not precisely specified beyond their occurrence on this date. The report from AP highlights the lack of new evidence supporting the president's claims. This follows earlier reports from September 22nd, where President Trump also linked autism to the pain relief drug Tylenol during an announcement on medical and scientific findings for America's children. At that time, the White House shared that autism rates among children had increased nearly 400% in the last 22 years, a figure also cited by Rapid Response. The Trump Administration's Autism Action Plan was also referenced in previous reporting.
